News Analysis: The Perils of Yoga for Men





MEN are famous for ignoring aches and pains. It’s macho. Men get physical exams less often than women. They tend to remain silent if worried about their health. When hurt, their impulse is to shun doctors and rely on home remedies, like avoiding heavy lifting to ease backaches. Male athletes play through injuries. It’s all about virility and manliness.




The stereotype has exceptions, of course. But denial of injury and ill health — from the relatively inconsequential to the grave — is common enough that physicians seek ways to encourage men to be more forthcoming.


So it pays to listen carefully when guys start talking about intolerable pain and upended lives. Doing so led me to an unexpected finding that I have confirmed in a trove of federal data. It suggests that yoga can be remarkably dangerous — for men.


Guys who bend, stretch and contort their bodies are relatively few in number, perhaps one in five out of an estimated 20 million practitioners in the United States and 250 million around the globe. But proportionally, they are reporting damage more frequently than women, and their doctors are diagnosing more serious injuries — strokes and fractures, dead nerves and shattered backs. In comparison, women tell mainly of minor upsets.


Men who are breaking the code of silence are doing so with physicians in hospital emergency rooms, who in turn report their findings to the federal government.


Their outspokenness reveals much about modern yoga and suggests ways it can be made safer. As a practitioner since 1970, I know some of the guy hazards personally and have learned through painful experience how to live with my inflexible body.


The male disclosures help explain one of the central mysteries of modern yoga — why it is largely a feminine pursuit. As Yoga Journal, the field’s top magazine, put the question: “Where Are All the Men?”


Science has long viewed the female body as relatively elastic. Now the new disclosures suggest that women who tie themselves in knots also enjoy a lower risk of damage. It seems like common sense.


Surprisingly, evidence of the male danger has, to my knowledge, never before been made public. Nor has its flip side — that women seem less vulnerable. The subject of male risk merits discussion if only because the booming yoga industry has long targeted men as a smart way to expand its franchise.


Informal observations hint at possible explanations. Yoga experts say women tend to see classes as refuges while men see challenges — their goal at times to impress the opposite sex.


Women say men push themselves too far, too fast. Men admit to liking the intensity but say the problem is pushy teachers who force them into advanced poses while urging them to ignore pain.


I stumbled on the issue after my book, published in February, laid out a century and a half of science and, in its chapter on injuries, contradicted the usual image of yoga as completely safe. The yoga establishment makes billions of dollars by selling itself as a path to healthy perfection. Predictably, it responded with sharp denials.


I also received a surprising number of moving replies from injured yogis — male and female — including stroke victims.


A letter initiated my inquiry. In April, a man told how an agonizing back injury had turned his life into “a living hell.” Too many instructors, he wrote, are “pushing us too hard and having us do dangerous poses.”


The “us” resonated.


Suddenly, I realized his cry sounded familiar.


I raced through a correspondence file and saw that many of the letters about serious damage had come from men.


Tara Stiles, a yoga teacher who runs a popular studio in Manhattan, told me that guys have more muscle (one reason for their relative inflexibility) and can thus force themselves into challenging poses they might otherwise find impossible. It seemed a plausible explanation for blinding pain.


Other teachers echoed her analysis and cited supporting anecdotes.


Yoga poses are unisex. But in my research, I found a world of poorly known information on gender disparity.


“Science of Flexibility,” by Michael J. Alter, explained how the pelvic regions of women are shaped in a way that permits an unusually large range of motion and joint play. In yoga, the pelvis is the central pivot for extreme bending of the legs, spine and torso.


In June, I turned to the Consumer Product Safety Commission and its National Electronic Injury Surveillance System, which monitors hospital emergency rooms. In July, officials sent me 18 years of annual survey data that summarized the admission records for yoga practitioners hurt between 1994 and 2011, the maximum available span.


First, I needed a baseline that would let me compare the guy admissions to males doing yoga in the United States. Figures in the yoga literature described men as making up some 10 percent of practitioners at the beginning of the period and 23 percent at the end. So the middle ground seemed to be roughly 16 percent.


Then I dug into the medical data. The analysis took weeks, but the results spoke volumes.


William J. Broad is a science reporter for The New York Times and the author of “The Science of Yoga: The Risks and the Rewards.”



Read More..

Syrian Resort Town Is Stronghold for Alawites





TARTUS, Syria — Loyalists who support the government of President Bashar al-Assad are flocking to the Mediterranean port of Tartus, creating an overflowing boomtown far removed from the tangled, scorched rubble that now mars most Syrian cities.







The New York Times

The port city of Tartus is sheltered by a mountain range.






There are no shellings or air raids to interrupt the daily calm. Families pack the cafes lining the town’s seaside corniche, usually abandoned in December to the salty winter winds. The real estate market is brisk. A small Russian naval base provides at least the impression that salvation, if needed, is near.


Many of the new residents are members of the Alawite minority, the same Shiite Muslim sect to which Mr. Assad belongs. The latest influx is fleeing from Damascus, people who have decided that summer villas, however chilly, are preferable to the looming battle for the capital.


“Going to Tartus is like going to a different country,” said a Syrian journalist who recently met residents here. “It feels totally unaffected and safe. The attitude is, ‘We are enjoying our lives while our army is fighting overseas.’ ”


Should Damascus fall to the opposition, Tartus could become the heart of an attempt to create a different country. Some expect Mr. Assad and the security elite will try to survive the collapse by establishing a rump Alawite state along the coast, with Tartus as their new capital.


There have been various signs of preparations.


This month, the governor of Tartus Province announced that experts were studying how to develop a tiny local airfield, now used mostly by crop-dusters, into a full-fledged civilian airport “to boost transportation, business, travel and tourism,” as the official Syrian news agency, SANA, reported. The announcement coincided with the first attacks on the airport in Damascus, forcing it to close temporarily to international traffic.


More important, security forces are continuously tightening an extensive ring of checkpoints around the potential borders of an Alawite canton. The mountain heartland of the Alawites rises steeply to the east of Tartus, separating it from much of Syria. Across the mountains, the Orontes River creates a rough line separating Alawite territory from central Syria. Rebel military commanders from adjoining Hama Province said government soldiers vigorously maintain checkpoints on routes leading up into the mountains.


“If we bomb a checkpoint, it is back in place sometimes within hours,” said Basil al-Hamwi, a rebel fighter, speaking on the sidelines of a meeting of opposition military commanders in Turkey. “Once, in Hama Province, we destroyed five in one day and they were all back the next day. This area is even more important for them than Damascus.”


Mr. Hamwi and other commanders said there were about 40 government checkpoints along more than 60 miles in Homs and Hama Provinces alone. Many Alawite commanders of Mr. Assad’s army have sent their families to their home villages, so they are particularly aggressive in protecting the area, said Hassan M. al-Saloom, a rebel battalion commander. They have formed committees to guard the outskirts of their villages, he said, and often negotiate local truces.


“Nobody goes inside, and they don’t come out,” he said.


There are widespread suspicions within the opposition that the military is shipping weapons into the Alawite hinterland, or has already positioned them. “The mountains and the coast make it hard to raid,” Mr. Saloom said.


Castles left by the Crusaders dot the coastal range, a testament to its strategic value.


If Mr. Assad fled to Tartus, he could seek protection from the Russian naval base here, or flee aboard a Russian vessel. Russia announced Tuesday that it was sending a small flotilla toward Tartus, possibly to evacuate its citizens who live in Syria. But Tartus residents said that the Russian families from the naval base had already left, while the officers do not leave the base, which is little more than an enclosure near the civilian port.


An employee of The New York Times reported from Tartus, and Neil MacFarquhar from Antakya, Turkey. Hania Mourtada contributed reporting from Beirut, Lebanon, and Hala Droubi from Dubai, United Arab Emirates.



Read More..

As Shoppers Hop From Tablet to PC to Phone, Retailers Try to Adapt


Jim Wilson/The New York Times


Shoppers often visit ModCloth, a Web site that sells women’s clothes, on their phones but return on a different kind of device to buy something, said Sarah Rose, a vice president at ModCloth.







Ryan O’Neil, a Connecticut government employee, was in the market to buy a digital weather station this month. His wife researched options on their iPad, but even though she found the lowest-price option there, Mr. O’Neil made the purchase on his laptop.




“I do use the iPad to browse sites,” Mr. O’Neil said, but when it comes time to close the deal, he finds it easier to do on a computer.


Many online retailers had visions of holiday shoppers lounging beneath the Christmas tree with their mobile devices in hand, making purchases. The size of the average order on tablets, particularly iPads, tends to be bigger than on PCs. So retailers poured money and marketing into mobile Web sites and apps with rich images and, they thought, easy checkout.


But while visits to e-commerce sites and apps on tablets and phones have nearly doubled since last year, consumers like Mr. O’Neil are more frequently using multiple devices to shop. In many cases, they are more comfortable making the final purchase on a computer, with its bigger screen and keyboard. So retailers are trying to figure out how to appeal to a shopper who may use a cellphone to research products, a tablet to browse the options and a computer to buy.


“I’ve been yelling at customers for two years, saying, ‘Mobile, mobile, mobile,’ ” said Jason Spero, director of mobile sales and strategy at Google. “But the funny thing is, now we’re going to say: ‘Don’t put mobile in a silo. It’s also about the desktop.’ ”


The challenges are daunting, though. It is technically difficult to track consumers as they hop from phone to computer to tablet and back again. This means customers who, say, fill shopping carts on their tablets have to do all the work again on their PCs or other devices. The biggest obstacle, retailers say, is that the tools used to track shoppers on computers — cookies, or bundles of data stored in Web browsers — don’t transfer across devices.


Instead, retailers are figuring out how to sync the experience in other ways, like prompting shoppers to log in on each device. And being able to track people across devices gives retailers more insight into how they shop.


The retailers’ efforts are backed by research. While one-quarter of the visits to e-commerce sites occur on mobile devices, only around 15 percent of purchases do, according to data from I.B.M. According to Google, 85 percent of online shoppers start searching on one device — most often a mobile phone — and make a purchase on another.


At eBags, customers are shopping on their tablets in the evening and returning on their work computers the next day. But eBags has not yet synced the shoppers across devices, so customers must build their shopping carts from scratch if they switch devices.


“That is a blind spot with a lot of sites,” said Peter Cobb, co-founder of eBags. “It is a requirement moving forward.”


At eBay, one-third of the purchases involve mobile devices at some point, even if the final purchase is made on a computer.


At eBay, once shoppers log in on a device, they do not need to log in again. Their information, like shipping and credit card details and saved items, syncs across all their devices. If an eBay shopper is interested in a certain handbag, and saves that search on a computer, eBay will send alerts to her cellphone when a new handbag arrives or an auction is about to end.


“They might discover an item on a phone or tablet, do a saved-search push alert later on some other screen and eventually close on the Web site,” said Steve Yankovich, who runs eBay Mobile. “People are buying and shopping and consuming potentially every waking moment of the day.”


ModCloth, an e-commerce site for women’s clothes, said that while a quarter of its visits come from mobile devices, people are not yet buying there in the same proportion, though they are becoming more comfortable with checking out on those devices.


“She’s visiting us more on the phone, but she’s actually transacting somewhere else,” said Sarah Rose, vice president of product at ModCloth.


For example, a shopper will skim through new arrivals on her phone while on the bus and add items to her wish list, then visit that evening on her tablet to make a purchase, Ms. Rose said.


Read More..

Genetic Gamble : New Drugs Aim to Make Cells Destroy Cancer


C.J. Gunther for The New York Times


Dr. Donald Bergstrom is a cancer specialist at Sanofi, one of three companies working on a drug to restore a tendency of damaged cells to self-destruct.







For the first time ever, three pharmaceutical companies are poised to test whether new drugs can work against a wide range of cancers independently of where they originated — breast, prostate, liver, lung. The drugs go after an aberration involving a cancer gene fundamental to tumor growth. Many scientists see this as the beginning of a new genetic age in cancer research.




Great uncertainties remain, but such drugs could mean new treatments for rare, neglected cancers, as well as common ones. Merck, Roche and Sanofi are racing to develop their own versions of a drug they hope will restore a mechanism that normally makes badly damaged cells self-destruct and could potentially be used against half of all cancers.


No pharmaceutical company has ever conducted a major clinical trial of a drug in patients who have many different kinds of cancer, researchers and federal regulators say. “This is a taste of the future in cancer drug development,” said Dr. Otis Webb Brawley, the chief medical and scientific officer of the American Cancer Society. “I expect the organ from which the cancer came from will be less important in the future and the molecular target more important,” he added.


And this has major implications for cancer philanthropy, experts say. Advocacy groups should shift from fund-raising for particular cancers to pushing for research aimed at many kinds of cancer at once, Dr. Brawley said. John Walter, the chief executive officer of the Leukemia and Lymphoma Society, concurred, saying that by pooling forces “our strength can be leveraged.”


At the heart of this search for new cancer drugs are patients like Joe Bellino, who was a post office clerk until his cancer made him too sick to work. Seven years ago, he went into the hospital for hernia surgery, only to learn he had liposarcoma, a rare cancer of fat cells. A large tumor was wrapped around a cord that connects the testicle to the abdomen. “I was shocked,” he said in an interview this summer.


Companies have long ignored liposarcoma, seeing no market for drugs to treat a cancer that strikes so few. But it is ideal for testing Sanofi’s drug because the tumors nearly always have the exact genetic problem the drug was meant to attack — a fusion of two large proteins. If the drug works, it should bring these raging cancers to a halt. Then Sanofi would test the drug on a broad range of cancers with a similar genetic alteration. But if the drug fails against liposarcoma, Sanofi will reluctantly admit defeat.


“For us, this is a go/no-go situation,” said Laurent Debussche, a Sanofi scientist who leads the company’s research on the drug.


The genetic alteration the drug targets has tantalized researchers for decades. Normal healthy cells have a mechanism that tells them to die if their DNA is too badly damaged to repair. Cancer cells have grotesquely damaged DNA, so ordinarily they would self-destruct. A protein known as p53 that Dr. Gary Gilliland of Merck calls the cell’s angel of death normally sets things in motion. But cancer cells disable p53, either directly, with a mutation, or indirectly, by attaching the p53 protein to another cellular protein that blocks it. The dream of cancer researchers has long been to reanimate p53 in cancer cells so they will die on their own.


The p53 story began in earnest about 20 years ago. Excitement ran so high that, in 1993, Science magazine anointed it Molecule of the Year and put it on the cover. An editorial held out the possibility of “a cure of a terrible killer in the not too distant future.”


Companies began chasing a drug to restore p53 in cells where it was disabled by mutations. But while scientists know how to block genes, they have not figured out how to add or restore them. Researchers tried gene therapy, adding good copies of the p53 gene to cancer cells. That did not work.


Then, instead of going after mutated p53 genes, they went after half of cancers that used the alternative route to disable p53, blocking it by attaching it to a protein known as MDM2. When the two proteins stick together, the p53 protein no longer functions. Maybe, researchers thought, they could find a molecule to wedge itself between the two proteins and pry them apart.


The problem was that both proteins are huge and cling tightly to each other. Drug molecules are typically tiny. How could they find one that could separate these two bruisers, like a referee at a boxing match?


In 1996, researchers at Roche noticed a small pocket between the behemoths where a tiny molecule might slip in and pry them apart. It took six years, but Roche found such a molecule and named it Nutlin because the lab was in Nutley, N.J.


But Nutlins did not work as drugs because they were not absorbed into the body.


Roche, Merck and Sanofi persevered, testing thousands of molecules.


At Sanofi, the stubborn scientist leading the way, Dr. Debussche, maintained an obsession with p53 for two decades. Finally, in 2009, his team, together with Shaomeng Wang at the University of Michigan and a biotech company, Ascenta Therapeutics, found a promising compound.


The company tested the drug by pumping it each day into the stomachs of mice with sarcoma.


Read More..

Genetic Gamble : New Drugs Aim to Make Cells Destroy Cancer


C.J. Gunther for The New York Times


Dr. Donald Bergstrom is a cancer specialist at Sanofi, one of three companies working on a drug to restore a tendency of damaged cells to self-destruct.







For the first time ever, three pharmaceutical companies are poised to test whether new drugs can work against a wide range of cancers independently of where they originated — breast, prostate, liver, lung. The drugs go after an aberration involving a cancer gene fundamental to tumor growth. Many scientists see this as the beginning of a new genetic age in cancer research.




Great uncertainties remain, but such drugs could mean new treatments for rare, neglected cancers, as well as common ones. Merck, Roche and Sanofi are racing to develop their own versions of a drug they hope will restore a mechanism that normally makes badly damaged cells self-destruct and could potentially be used against half of all cancers.


No pharmaceutical company has ever conducted a major clinical trial of a drug in patients who have many different kinds of cancer, researchers and federal regulators say. “This is a taste of the future in cancer drug development,” said Dr. Otis Webb Brawley, the chief medical and scientific officer of the American Cancer Society. “I expect the organ from which the cancer came from will be less important in the future and the molecular target more important,” he added.


And this has major implications for cancer philanthropy, experts say. Advocacy groups should shift from fund-raising for particular cancers to pushing for research aimed at many kinds of cancer at once, Dr. Brawley said. John Walter, the chief executive officer of the Leukemia and Lymphoma Society, concurred, saying that by pooling forces “our strength can be leveraged.”


At the heart of this search for new cancer drugs are patients like Joe Bellino, who was a post office clerk until his cancer made him too sick to work. Seven years ago, he went into the hospital for hernia surgery, only to learn he had liposarcoma, a rare cancer of fat cells. A large tumor was wrapped around a cord that connects the testicle to the abdomen. “I was shocked,” he said in an interview this summer.


Companies have long ignored liposarcoma, seeing no market for drugs to treat a cancer that strikes so few. But it is ideal for testing Sanofi’s drug because the tumors nearly always have the exact genetic problem the drug was meant to attack — a fusion of two large proteins. If the drug works, it should bring these raging cancers to a halt. Then Sanofi would test the drug on a broad range of cancers with a similar genetic alteration. But if the drug fails against liposarcoma, Sanofi will reluctantly admit defeat.


“For us, this is a go/no-go situation,” said Laurent Debussche, a Sanofi scientist who leads the company’s research on the drug.


The genetic alteration the drug targets has tantalized researchers for decades. Normal healthy cells have a mechanism that tells them to die if their DNA is too badly damaged to repair. Cancer cells have grotesquely damaged DNA, so ordinarily they would self-destruct. A protein known as p53 that Dr. Gary Gilliland of Merck calls the cell’s angel of death normally sets things in motion. But cancer cells disable p53, either directly, with a mutation, or indirectly, by attaching the p53 protein to another cellular protein that blocks it. The dream of cancer researchers has long been to reanimate p53 in cancer cells so they will die on their own.


The p53 story began in earnest about 20 years ago. Excitement ran so high that, in 1993, Science magazine anointed it Molecule of the Year and put it on the cover. An editorial held out the possibility of “a cure of a terrible killer in the not too distant future.”


Companies began chasing a drug to restore p53 in cells where it was disabled by mutations. But while scientists know how to block genes, they have not figured out how to add or restore them. Researchers tried gene therapy, adding good copies of the p53 gene to cancer cells. That did not work.


Then, instead of going after mutated p53 genes, they went after half of cancers that used the alternative route to disable p53, blocking it by attaching it to a protein known as MDM2. When the two proteins stick together, the p53 protein no longer functions. Maybe, researchers thought, they could find a molecule to wedge itself between the two proteins and pry them apart.


The problem was that both proteins are huge and cling tightly to each other. Drug molecules are typically tiny. How could they find one that could separate these two bruisers, like a referee at a boxing match?


In 1996, researchers at Roche noticed a small pocket between the behemoths where a tiny molecule might slip in and pry them apart. It took six years, but Roche found such a molecule and named it Nutlin because the lab was in Nutley, N.J.


But Nutlins did not work as drugs because they were not absorbed into the body.


Roche, Merck and Sanofi persevered, testing thousands of molecules.


At Sanofi, the stubborn scientist leading the way, Dr. Debussche, maintained an obsession with p53 for two decades. Finally, in 2009, his team, together with Shaomeng Wang at the University of Michigan and a biotech company, Ascenta Therapeutics, found a promising compound.


The company tested the drug by pumping it each day into the stomachs of mice with sarcoma.


Read More..

Preoccupations: When Relocation Is a Way of Life





ON New Year’s Day, the company I work for, Four Seasons Hotels and Resorts, will move me from Washington to Paris, where I will become a regional vice president of the company and general manager of the Hotel George V, which it manages.







Daniel Rosenbaum for The New York Times

Gathering the frequent-mover miles: From left are Christian and Meg Clerc, and their daughters, Eleanor and Georgia, at home in Washington.







My wife, Meg, teaches at a Montessori school. She and our teenage daughters, Eleanor and Georgia, will reunite with me at the end of the school year. It’s the seventh move for Meg and me: about every three years for the last two decades, we’ve packed and unpacked, and left newfound schools, friends, cars, dry cleaners, banks and homes, and found newer ones.


If you want to advance in the hotel industry, you’d better be able to check “yes” next to the box that asks, “Willing to relocate?” Mobility must be in your DNA if you want to move up. Originally from Switzerland, I myself have moved eight times over 25 years of working in hotels, rising from hotel restaurant food runner to hotel general manager: from Gstaad to Lausanne, Switzerland; then to Washington, Rome, Paris and back to Washington, then to Puerto Vallarta, Mexico, and to Chicago and Washington once more. Eleanor, now 17, was born in Rome. Georgia, 14, joined the journey on our first assignment in Washington.


Meg knew the score — and welcomed the global lifestyle — when she married me. In fact, she chose a mobile career herself, knowing that there would be Montessori schools worldwide.


The company provides good logistical support when it moves its employees. And on the home front, we have grown increasingly adaptive, and the moves have become easier over the years. The process begins when I first realize that a move may be in the works. Meg and I go out for lunch or coffee and review our trusty to-do list to become move-ready. Then we take our daughters out to lunch or dinner and broach the subject, beginning with “How would you feel if we moved to X?”


The worst reaction was when we planned to move back to Washington from Chicago less than a year after arriving there from Mexico. We thought the girls would be thrilled to reunite with friends in a familiar place. We thought wrong. In unison, they broke out in tears; they had just made new friends and were starting to fit in again.


Meg, so skilled at working with children as a teacher, had them talk about the roots of their fears and sadness, which usually revolve around establishing new social networks. I, racked by guilt about upsetting their cart again, blurted that they could get the puppy they had been begging for. (I had been adamantly opposed until then.) The tears stopped. Needless to say, our pup, Snickers, will be moving to Paris, too.


To stay sane at relocation time, we keep the house we’re in as homey as possible until we move, then turn the new house into a home as fast as we can. That way, we don’t have to stare at cardboard boxes on both ends of the trip. We can pack in two weeks.


Moving makes you prioritize what’s important. You have to decide what’s crucial enough to bring, and what’s marginal enough to leave behind. With friends, you have to choose those to see before you go, and the ones you want to stay in touch with after the move.


Each of us has certain things we take along — our “transitional objects.” For example, I need the big wooden credenza that’s been in my family for generations, a great coffee machine, my A.S. Roma soccer-club shirt and my watch box — after all, I am Swiss. For Meg, it’s not about things, but about creating a cozy, well-lit new space. The girls still bring their favorite stuffed animals along with photos, but their most important transitional object is each other.


BUILDING a new network of friends can be as daunting for Meg and me as it is for the girls. We’ve found friends among new work colleagues and through tight-knit expat communities. But there’s a danger of getting stuck in a cultural bubble and never befriending local people.


Our moves have brought us a great appreciation of cultural differences. The ability to adapt quickly to change helps in all kinds of situations. The moves have also prepared our daughters to make new friends quickly. Still, we wonder and worry how it will affect their future relationships. Will they have trouble forming long-lasting bonds?


We find inspiration, meanwhile, in
the lyrics of “You’re My Home,” the Billy Joel song: “I never had a place that I could call my very own, but that’s
all right, my love, ’cause you’re my home.”


As told to Perry Garfinkel.



Read More..

U.N. Panel Votes to Help Mali’s Army Oust Extremists





The United Nations Security Council unanimously approved a resolution on Thursday that will send thousands of African troops into the desert nation of Mali to help oust Islamist extremists who have turned its northern half into a vast Qaeda enclave and training ground, menacing the stability of neighboring states and posing a potent new international terrorism threat.




But the resolution also makes it clear that such a military intervention will not happen until Mali’s own dysfunctional army is adequately trained and a framework for political stability and elections is restored in the country, which has been in turmoil since a military coup in March.


The resolution, which was sponsored by France, the former colonial power in Mali, does not specify a time frame for the first deployment of foreign troops, to be supplied by a group of West African nations that are eager to see calm restored in Mali. United Nations officials and diplomats who worked on the resolution said that a 3,300-soldier force would be sent, and that any attempt to drive the Islamists from northern Mali would not happen before September or October at the earliest.


The resolution does not explain precisely how the military expedition, which is to last for an initial period of one year, will be financed, although diplomats said they expected the cost to exceed $200 million. The resolution calls for voluntary contributions from member states into a trust fund to be created by Secretary General Ban Ki-moon.


Despite the caveats, the Security Council’s vote authorizing military force, which it is empowered to do by the United Nations Charter, represented a rare moment of decisive unanimity among its 15 member states and in particular its 5 permanent members — Britain, China, France, Russia and the United States — in a year punctuated by bitter disagreements, mostly over the Syrian conflict.


“Everyone knows the complexity of the task facing the international community to restore the territorial integrity of Mali and to put an end to terrorist activities in the north of the country,” GĂ©rard Araud, France’s ambassador, told reporters after the vote. The resolution, he said, “provides a reasonable answer.”


Ideally, Mr. Araud said, the mere threat of military intervention would persuade Islamist militia leaders to negotiate a peaceful restoration of control by Mali’s central government. “It is premature to indicate when the military operation will take place,” he said. “In fact, the question is even whether the military operation will take place. Our goal would be to have a real political process which will allow the Malian Army to go back to its barracks in the northern part of the country without fighting.”


The final version of the resolution reflected what diplomats called some compromises between France and the United States, which had been skeptical that the Malian Army could be made capable of participating in a potentially long and violent struggle to retake the country’s northern area, roughly twice the size of Germany.


The resolution specifies that the European Union will be responsible for training the Malian forces, described as “vital to ensure Mali’s long-term security and stability.” It also specifies that the secretary general must regularly inform the Council on political and military-training progress, and “confirm in advance the Council’s satisfaction with the planned military offensive operation.”


Language was also included specifically intended to guard against human rights abuses by the Malian military in any operation in the north, where ethnic tensions linked to the occupation by Islamist militants are known to be on the rise. A report released Thursday by Human Rights Watch enumerated instances of abuses in Mali committed by security forces and others since the military coup.


Tens of thousands of Malians have fled the north since Islamist militias seized control there after the coup, which left a power vacuum that has yet to be resolved. Just last week, military generals forced the resignation of Prime Minister Cheick Modibo Diarra, in office since April.


The principal Islamist militia, known as Ansar Dine, or Defenders of the Faith, has imposed harsh Shariah law based on strict Islamic tenets and enforced it with public killings, stonings and amputations. The group has also welcomed Al Qaeda in the Islamic Maghreb, the affiliate of Al Qaeda in northern Africa, which has recruited child soldiers, established training camps and reached out to other militant Islamist organizations, including Boko Haram, a particularly violent group in northern Nigeria.


Rights activists monitoring the Mali crisis had a mixed reaction to the Security Council resolution. While they welcomed action against abuses by the Islamists, some expressed concern that the Malian Army, humiliated by the loss of half the country, would be bent on revenge.


Michael Quinn, country director of the aid group Oxfam in Mali, said the Security Council “must make sure that any military planning includes humanitarian consideration to minimize harm to civilians at all stages.”


Read More..

Noted: A Vibrator That Will Make Her Thankful for the Memory





FLASH memory drives come in many odd forms — disguised as plastic sushi pieces, Swiss Army knives and Hello Kitty figures. Now, a contender for the oddest: a vibrator.




An erotic toy with built-in flash memory is the latest addition to a growing, evolving industry. The toy’s maker is Crave, a new San Francisco company begun by a Stanford University designer-engineer whose Duet vibrator started showing up this year in stores like Good Vibrations in San Francisco and Babeland in New York and recently hit a handful of boutique retailers around the country.


The Duet Lux looks like a sleek tuning fork, with a silicone tip and a gold-plated band. Open it up and discover a USB port with 8 gigabytes of memory (for $219), or pay $349 for 16 gigs and a gold-plated base.


The obvious question: Why computer memory? Has multitasking jumped the shark?


Including memory was not Crave’s original intent. The idea was simply that the device’s USB port would be chargeable by computer, eliminating the need for cords or batteries.


But “a bunch of the testers asked: ‘Can we store stuff on this?’ ” said Michael Topolovac, a co-founder of Crave and a Stanford graduate who has founded two previous start-ups, one building underwater cameras and the other cloud computing software.


Mr. Topolovac said testers and others explained that they would like to use vibrator memory to store private material — not just erotic files, but documents. Users can remove the vibrating part at the top, he said, and be left with what might pass at a Starbucks as just a fancy flash memory stick. “I use it for my V.C. presentations,” he added.


More broadly, the Duet looks to be an exception that proves the rule. The exception: Mr. Topolovac said there do not appear to be other vibrators on the market with a built-in computer memory, though there are a growing number that can be charged through via USB ports.


The rule proved by the exception: a lot of design and innovation is coming to the vibrator category, reflecting a growing mainstream retail market. Last year, for instance, Walgreens began carrying Trojan-made vibrators, alongside other personal items like lubricant. In the third quarter of 2012, Trojan said, it sold 273,000 vibrators at food, drug and mass retailers (like Walgreens, CVS and Duane Reade), citing Nielsen, a market research firm.


Last year, Brookstone started selling a line of Pleasure Objects, vibrators made by a company called Lelo. It, and other companies, have been pushing luxury and design-centric vibrators, hoping to keep moving the business from one with a reputation for novelty toys toward lifestyle brands.


In the case of Crave, adding computer memory to a sex toy is just the beginning of the innovation.


“Next year, we’ll be introducing products with memory and wireless capability,” Mr. Topolovac said. Wireless? “To control the device,” he said vaguely, but declined to elaborate as to exactly how that might work or why it would be useful, citing that Silicon Valley standby: fear of divulging intellectual property secrets before their time.


Crave draws not just its ethos but its heroes from Silicon Valley. Crave’s other co-founder, Ti Chang, is a woman with an industrial design background who Mr. Topolovac insists can become to vibrators what Jonathan Ive, the design guru at Apple, is to user-friendly computing.


“On my best day, I’m a mediocre Steve Jobs,” he said, “and her regular day, she’s a Jony Ive.”


Read More..

For Tracy Anderson, Fitness Expert, Always a New Move


Erin Baiano for The New York Times


Tracy Anderson, center, teaching a fitness class at her studio in TriBeCa. Her classes and DVDs have attracted devoted followers — and, she says, mimics.







TRACY ANDERSON, the tiny blond fitness guru perhaps best known as Gwyneth Paltrow’s trainer and business partner, is as bright and sparkly as the Swarovski crystal-encrusted iPhone case she was admiring one recent Thursday.




“I love this!” she squealed, bouncing on the sofa of the Greenwich Hotel. Then she turned the case over and spied a fighting word: Soul, short for SoulCycle, a popular chain of cycling studios in New York and Los Angeles.


She looked as if she had swallowed something sour, and nearly dropped the bejeweled case. Her girlishness disappeared, and she said flatly: “I can get you better legs than them.”


Ms. Anderson, 37, claims that SoulCycle, through a former employee of hers, uses one of her inventions: a system of resistance bands that hangs from the ceiling. (A SoulCycle spokeswoman had no comment.)


The cycling studios are just one target of the combative Ms. Anderson. At least half a dozen of her former employees have released exercise DVDs or have opened their own studios — their clients include Madonna, Anne Hathaway and Kelly Ripa — many peddling workouts she said were derived in “an opportunistic way” from the intense, heart-in-throat dance routines and minimal-weight, high-repetition “muscular structure” moves Ms. Anderson has spent 14 years perfecting.


Her influence can be found in almost any gym featuring the type of jump-heavy cardio dance classes she has popularized or a version of what Ms. Anderson calls her “weird free arms” — essentially waving the arms from every conceivable angle for minutes at a time.


“It makes me sad for humanity, actually, that people would take all my hard work and then pose like they have a method that they have tried and tested,” she said of her former employees, becoming so angry she struggled for words. “They’re not even lip-syncing what I do. They’re, like, karaokeing off my songs.”


She added: “But the nice thing about it is that as a company, Gwyneth and I have been really smart like Coca-Cola and we didn’t teach any of those trainers how or why I move the way I do.”


Ms. Anderson, who was born in Indiana, studied musical theater for two years at the American Musical and Dramatic Academy in New York. She insisted she did not owe anything to Jane Fonda, the original dance aerobics queen, because Ms. Fonda was “a motivator, but she never claimed to have a method.”


Ms. Anderson described her own philosophy as “the method,” and talked passionately about the science behind it, tossing around terms like “proprioception perception,” “strength of synapses” and “muscle confusion.”


“I move across the large muscles in a way like when you were a kid you got an Indian burn, building collective strength between muscle groups,” she explained with a smile.


Ms. Anderson has not sought certification in fields like exercise physiology or teaching, she said, because, “I am so hard on myself with not deviating the amount of time that I have for research and development of the method.”


As for coming up with moves to slim problem areas where women are predisposed to store fat (“disproportionate struggle,” in Ms. Andersonspeak), she painted a vivid picture.


“I’m completely focused on how can I get forces to travel from opposing directions and end up creating a contraction in a muscle that’s going to then pull in,” she said. “And then as we lose the fat the muscular structure will be vibrating so well that it will have the connective tissues pull the skin back to it.”


Richard Cotton, an exercise physiologist and the national director of training for the American College of Sports Medicine in Indianapolis, said there is “a ton of research that disputes the idea of spot-reduction.”


“You can’t choose where the body loses fat,” he said.


Gary Diffee, a professor of kinesiology at the University of Wisconsin-Madison who examined some of her claims, said, “Like many things of this type, the science seems to be a mixture of true, kind of true, true but irrelevant to the point she is trying to make, and wrong.”


“The main thing is that she is getting people to move,” Dr. Diffee said.


Read More..

For Tracy Anderson, Fitness Expert, Always a New Move


Erin Baiano for The New York Times


Tracy Anderson, center, teaching a fitness class at her studio in TriBeCa. Her classes and DVDs have attracted devoted followers — and, she says, mimics.







TRACY ANDERSON, the tiny blond fitness guru perhaps best known as Gwyneth Paltrow’s trainer and business partner, is as bright and sparkly as the Swarovski crystal-encrusted iPhone case she was admiring one recent Thursday.




“I love this!” she squealed, bouncing on the sofa of the Greenwich Hotel. Then she turned the case over and spied a fighting word: Soul, short for SoulCycle, a popular chain of cycling studios in New York and Los Angeles.


She looked as if she had swallowed something sour, and nearly dropped the bejeweled case. Her girlishness disappeared, and she said flatly: “I can get you better legs than them.”


Ms. Anderson, 37, claims that SoulCycle, through a former employee of hers, uses one of her inventions: a system of resistance bands that hangs from the ceiling. (A SoulCycle spokeswoman had no comment.)


The cycling studios are just one target of the combative Ms. Anderson. At least half a dozen of her former employees have released exercise DVDs or have opened their own studios — their clients include Madonna, Anne Hathaway and Kelly Ripa — many peddling workouts she said were derived in “an opportunistic way” from the intense, heart-in-throat dance routines and minimal-weight, high-repetition “muscular structure” moves Ms. Anderson has spent 14 years perfecting.


Her influence can be found in almost any gym featuring the type of jump-heavy cardio dance classes she has popularized or a version of what Ms. Anderson calls her “weird free arms” — essentially waving the arms from every conceivable angle for minutes at a time.


“It makes me sad for humanity, actually, that people would take all my hard work and then pose like they have a method that they have tried and tested,” she said of her former employees, becoming so angry she struggled for words. “They’re not even lip-syncing what I do. They’re, like, karaokeing off my songs.”


She added: “But the nice thing about it is that as a company, Gwyneth and I have been really smart like Coca-Cola and we didn’t teach any of those trainers how or why I move the way I do.”


Ms. Anderson, who was born in Indiana, studied musical theater for two years at the American Musical and Dramatic Academy in New York. She insisted she did not owe anything to Jane Fonda, the original dance aerobics queen, because Ms. Fonda was “a motivator, but she never claimed to have a method.”


Ms. Anderson described her own philosophy as “the method,” and talked passionately about the science behind it, tossing around terms like “proprioception perception,” “strength of synapses” and “muscle confusion.”


“I move across the large muscles in a way like when you were a kid you got an Indian burn, building collective strength between muscle groups,” she explained with a smile.


Ms. Anderson has not sought certification in fields like exercise physiology or teaching, she said, because, “I am so hard on myself with not deviating the amount of time that I have for research and development of the method.”


As for coming up with moves to slim problem areas where women are predisposed to store fat (“disproportionate struggle,” in Ms. Andersonspeak), she painted a vivid picture.


“I’m completely focused on how can I get forces to travel from opposing directions and end up creating a contraction in a muscle that’s going to then pull in,” she said. “And then as we lose the fat the muscular structure will be vibrating so well that it will have the connective tissues pull the skin back to it.”


Richard Cotton, an exercise physiologist and the national director of training for the American College of Sports Medicine in Indianapolis, said there is “a ton of research that disputes the idea of spot-reduction.”


“You can’t choose where the body loses fat,” he said.


Gary Diffee, a professor of kinesiology at the University of Wisconsin-Madison who examined some of her claims, said, “Like many things of this type, the science seems to be a mixture of true, kind of true, true but irrelevant to the point she is trying to make, and wrong.”


“The main thing is that she is getting people to move,” Dr. Diffee said.


Read More..